Dextran Completed Phase 4 Trials for Allergic Conjunctivitis (AC) Prevention

Indications	Status	Purpose	Phase
DBCOND0076634 (Allergic Conjunctivitis (AC))	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT01534195	Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model	Dextran (DB09255) Hypromellose (DB11075) Prednisolone (DB00860)